Neurolutions is a medical device company creating a revolutionary platform for neurorehabilitation leveraging BCI technology.
Neurolutions has raised $26.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Neurolutions's investors include BioGenerator, Ascension Ventures, AMED Ventures, St. Louis Arch Angels, Prolog Ventures.
Neurolutions is headquartered in Van Nuys, United States.
Neurolutions is a medical device company creating a revolutionary platform for neurorehabilitation leveraging BCI technology.
Neurolutions is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Neurolutions — Funding & Investors." VCBacked, March 14, 2025, https://www.vcbacked.co/company/neurolutions. Accessed August 6, 2026.
VCBacked. (2025). Neurolutions — Funding & Investors. Retrieved August 6, 2026, from https://www.vcbacked.co/company/neurolutions
{{cite web |title=Neurolutions — Funding & Investors |url=https://www.vcbacked.co/company/neurolutions |website=VCBacked |access-date=August 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated